国际妇产科学杂志 ›› 2009, Vol. 36 ›› Issue (6): 450-453.

• 综述 • 上一篇    下一篇

丝裂原活化蛋白激酶信号转导通路与卵巢癌

焦今文;尚雪;朱一迪;温放   

  1. 110001 沈阳, 中国医科大学附属第一医院妇科
  • 收稿日期:2009-04-10 修回日期:1900-01-01 出版日期:2009-12-15 发布日期:2009-12-15
  • 通讯作者: 温放

The Correlation Between MAPK Signal Transduction and Ovarian Cancer

JIAO Jin-wen;SHANG Xue;ZHU Yi-di;WEN Fang   

  1. The First Affiliated Hospital, China Medical University, Shenyang 110001, China
  • Received:2009-04-10 Revised:1900-01-01 Published:2009-12-15 Online:2009-12-15
  • Contact: WEN Fang

摘要: 丝裂原活化蛋白激酶(MAPK)信号转导通路是哺乳动物细胞内广泛存在的一类丝/苏氨酸蛋白激酶,与细胞增殖和凋亡密切相关,在近年信号转导领域中研究最多,与肿瘤细胞的发生、侵袭、转移及化疗耐药等有重要关系。已证明,MAPK信号转导通路在卵巢癌细胞中明显升高,并参与卵巢癌化疗耐药。现阶段研究多是基础实验,临床研究待开展。研究进展将为卵巢癌治疗提供新靶点。综述MAPK信号通路研究进展,重点论述其与卵巢癌的关系和化疗耐药机制,以及MAPK信号通路抑制剂在肿瘤防治方面的临床应用的前景。

关键词: 丝裂原活化蛋白激酶, 信号通路, 卵巢

Abstract: Mitogen-activated protein kinases (MAPK) signal transduction pathway is a class of serine/threonine protein kinase existed broadly in mammalian cells. It is closely related to cell proliferation and apoptosis. In recent years it is mostly studied in signal transduction research. Studies show that they play an important role in occurrence, invasion, metastasis and chemoresistance of tumor cells. It is proved that MAPK signal transduction pathway significantly increased in ovarian cancer cells, and participated in ovarian cancer chemoresistance. At this stage many experiments are basic researches, and its clinical research need further progress. Those reseaching progresses will provide new treating targets for ovarian cancer treatment. This review summarizes the current status of research on MAPK signal transduction pathway, emphatically on the relationship between MAPK signal transduction and ovarian cancer and the chemotherapy-resistant mechanism. There is also a discussion about the use of MAPK pathway inhibitors in cancer prevention and treatment in this review.

Key words: Mitogen-activated protein kinase, Signal pathway, Ovarian cancer